Skip to main content
. 2023 Nov 29;20(3):1497–1514. doi: 10.1002/alz.13523

TABLE 1.

Descriptive statistics of all harmonized measures across samples.

Variable Rush‐MAP ROS WUSM‐MAP EAS GSOEP HRS LISS SATSA
Big Five personality traits
Measurement tool NEO‐FFI NEO‐FFI NEO‐PI R IPIP NEO BFI‐S MIDI IPIP50 Eysenck
Extraversion 5.50 (1.69) 5.17 (1.65) 5.73 (1.67) 5.59 (1.75) 6.40 (1.88) 7.33 (1.85) 5.64 (1.62) 6.33 (0.74)
Agreeableness 5.33 (1.40) 6.37 (1.62) 6.73 (1.87) 7.45 (1.63) 8.42 (1.59) 6.68 (1.48) 7.23 (1.17)
Conscientiousness 6.25 (1.57) 6.27 (1.39) 6.31 (1.79) 6.95 (1.73) 8.21 (1.55) 7.85 (1.61) 6.34 (1.49) 7.05 (1.35)
Neuroticism 3.65 (1.68) 4.59 (1.61) 3.94 (1.91) 3.56 (2.08) 4.92 (2.04) 3.51 (2.06) 6.03 (1.69) 6.53 (1.35)
Openness to experience 5.50 (1.51) 5.60 (59) 5.85 (2.03) 5.88 (2.01) 6.44 (1.87) 5.98 (1.34) 4.84 (1.34)
Subjective well‐being
Positive affect 8.46 (1.82) 8.20 (3.86) 6.22 (2.15) 6.56 (1.93) 5.94 (1.67) 7.47 (2.12)
Negative affect 1.06 (1.30) 3.63 (1.98) 1.92 (1.81) 1.75 (1.76) 2.14 (2.29)
Satisfaction with life 7.39 (1.78) 6.75 (2.20) 7.00 (1.76) 6.08 (2.34) 6.56 (1.46) 5.75 (2.87)
Clinical dementia diagnosis
Valid N 4283 3374 1478 813 31,072 14,001 6543 2002
Clinical dementia 444 (22.17%) 428 (30.77%) 232 (27.39%) 44 (5.67%) 180 (1.03%) 1130 (7.98%) 20 (0.31%) 163 (8.14%)
Mean dementia follow‐up (years) 5.48 (4.14) 9.56 (6.61) 15.59 (22.11) 2.70 (2.92) 11.20 (0.48) 6.76 (2.26) 5.19 (4.43) 21.00 (0.00)
Neuropathology
Valid N 1721 1525 627 37
Mean neuropathology follow‐up (years) 6.16 (3.62) 10.46 (6.04) 14.83 (22.50) 7.29 (3.52)
Braak stage 3.77 (1.20) 3.58 (1.25) 4.01 (1.66) 3.12 (1.06)
CERAD 2.16 (1.12) 2.22 (1.13) 2.46 (0.81)

Lewy body disease

177 (23.14%) 177 (23.44%) 58 (38.67%) 4 (11.76%)
Gross cerebral infarcts 298 (37.91%) 271 (34.70%) 158 (100.00%)
Gross cerebral microinfarcts 260 (33.08%) 245 (31.37%) 27 (17.09%)
Cerebral atherosclerosis 1.13 (0.77) 1.24 (0.78) 1.29 (0.76)
Cerebral amyloid angiopathy 1.29 (0.95) 1.29 (0.97) 1.27 (0.88)
Arteriosclerosis 1.03 (0.91) 0.99 (0.96) 1.42 (0.70)
Hippocampal sclerosis 69 (9.77%) 56 (7.64%) 3 (3.66%) 4 (11.76%)
TDP‐43 428 (54.31%) 353 (49.79%) 27 (31.40%)
Covariates
Age 81.12 (6.96) 76.53 (7.24) 71.37 (10.39) 79.57 (5.39) 48.51 (16.93) 67.93 (10.45) 46.54 (15.94) 59.76 (14.02)
Gender (% female) 532 (25.93%) 417 (28.64%) 474 (56.63%) 476 (61.34%) 9166 (52.48%) 8438 (59.56%) 3568 (54.53%) 1177 (58.79%
Education 14.87 (3.15) 18.25 (3.48) 15.71 (2.95) 14.46 (3.39) 11.60 (2.52) 12.61 (3.08) 12.60 (4.19) 10.32 (1.82)
Global cognition 6.55 (1.02) 6.43 (0.98) 3.92 (1.29) 4.98 (0.81) 7.18 (1.58) 3.08 (2.81) 5.49 (1.35)
Body mass index (BMI) 27.03 (5.02) 27.32 (5.39) 28.28 (5.09) 25.61 (4.35) 27.66 (4.42) 25.42 (7.82) 25.50 (3.80)
Self‐rated health 3.93 (2.94) 6.75 (2.30) 6.36 (2.78) 5.39 (1.89) 2.16 (2.79)
Smokes 870 (42.52%) 285 (19.57%) 97 (11.58%) 423 (54.51%) 5617 (33.97%) 7935 (56.01%) 4009 (61.97%) 998 (49.85%)
Alcohol use 596 (36.01%) 362 (27.57%) 44 (5.25%) 714 (92.01%) 9800 (58.31%) 7523 (53.10%) 5953 (92.02%) 1334 (67.89%)
Race (% Other) 361 (17.59%) 224 (15.38%) 126 (15.05%) 343 (44.20%) 5074 (35.82%)
Stroke 174 (9.26%) 96 (6.95%) 17 (2.03%) 34 (4.38%) 0 (0.00%) 1410 (9.95%) 52 (0.81%) 40 (2.06%)
Cancer 676 (32.96%) 444 (30.49%) 56 (6.68%) 136 (17.62%) 0 (0.00%) 2500 (17.65%) 104 (1.62%) 77 (3.98%)
Diabetes 275 (13.41%) 193 (13.26%) 75 (8.95%) 141 (18.24%) 0 (0.00%) 3376 (23.83%) 305 (4.76%) 124 (6.38%)
Heart problems 249 (12.15%) 147 (10.10%) 70 (8.35%) 170 (21.91%) 4367 (30.83%) 252 (3.93%) 667 (33.91%)

Note: Sample sizes are based on the number of participants with at least one personality trait or well‐being measurement occasion and at least one valid dementia diagnosis or neuropathology indicator. Age, education, gender, smoking, alcohol, BMI, chronic conditions, and cognition were assessed at the first baseline personality assessment. See supplementary materials for full details on cognitive measures and scoring across samples. No. cases (%) values represent binary indicators (eg, No. women [proportion of women] for gender), while continuous indicators are presented as M (SD).